Inmune Bio Inc. (INMB)
NASDAQ · Healthcare
Inmune Bio Inc. Long Term Debt 2017–2025
Inmune Bio Inc. annual long term debt history from 2021 to 2024. Long term debt refers to financial obligations that are due more than one year in the future.
- Inmune Bio Inc. long term debt as of December 31, 2024: 15.0M, a 0.00% increase year-over-year.
- Inmune Bio Inc. long term debt for 2024 were 15.0M, a 0.00% increase from 2022.
- Inmune Bio Inc. long term debt for 2022 were 15.0M, a 0.00% increase from 2021.
- Inmune Bio Inc. long term debt for 2021 were 15.0M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Inmune Bio Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2024 | $15 |
| 2022 | $15 |
| 2021 | $15 |
Inmune Bio Inc. Long Term Debt — FAQ
Inmune Bio Inc. (INMB) long term debt over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see INMB's long term debt history?
The chart and table above show Inmune Bio Inc.'s long term debt by year and by quarter, including the growth rate.